16.09.2015 Views

Clinical Pharmacology and Therapeutics

A Textbook of Clinical Pharmacology and ... - clinicalevidence

A Textbook of Clinical Pharmacology and ... - clinicalevidence

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

PHARMACODYNAMIC CHANGES 57<br />

DISTRIBUTION<br />

Ageing is associated with loss of lean body mass, <strong>and</strong> with an<br />

increased ratio of fat to muscle <strong>and</strong> body water. This enlarges<br />

the volume of distribution of fat-soluble drugs, such as<br />

diazepam <strong>and</strong> lidocaine, whereas the distribution of polar<br />

drugs such as digoxin is reduced compared to younger adults.<br />

Changes in plasma proteins also occur with ageing, especially<br />

if associated with chronic disease <strong>and</strong> malnutrition, with a fall<br />

in albumin <strong>and</strong> a rise in gamma-globulin concentrations.<br />

HEPATIC METABOLISM<br />

There is a decrease in the hepatic clearance of some but not all<br />

drugs with advancing age. A prolonged plasma half-life (Figure<br />

11.2), can be the result either of reduced clearance or of increased<br />

apparent volume of distribution. Ageing reduces metabolism of<br />

some drugs (e.g. benzodiazepines) as evidenced by reduced<br />

hepatic clearance. The reduced clearance of benzodiazepines<br />

has important clinical consequences, as does the long half-life of<br />

several active metabolites (Chapter 18). Slow accumulation may<br />

lead to adverse effects whose onset may occur days or weeks<br />

after initiating therapy. Consequently, confusion or memory<br />

impairment may be falsely attributed to ageing rather than to<br />

adverse drug effects.<br />

Diazepam t 1/2 (h)<br />

120<br />

100<br />

80<br />

60<br />

40<br />

20<br />

0 10 20 30 40 50 60 70 80 100<br />

Age (years)<br />

Figure 11.2: Relationship between diazepam half-life <strong>and</strong> age in<br />

33 normal individuals. Non-smokers,<br />

° ; smokers, •. (Redrawn<br />

with permission from Klotz U et al. Journal of <strong>Clinical</strong><br />

Investigation 1975; 55: 347.)<br />

Table 11.1: Examples of drugs requiring dose adjustment in the elderly<br />

Aminoglycosides (e.g. gentamicin)<br />

Atenolol<br />

Cimetidine<br />

Diazepam<br />

Digoxin<br />

Non-steroidal anti-inflammatory drugs<br />

Oral hypoglycaemic agents<br />

Warfarin<br />

RENAL EXCRETION<br />

The most important cause of drug accumulation in the elderly<br />

is declining renal function. Many healthy elderly individuals<br />

have a glomerular filtration rate (GFR) 50 mL/min. Although<br />

glomerular filtration rate declines with age, this is not necessarily<br />

reflected by serum creatinine, which can remain within the<br />

range defined as ‘normal’ for a younger adult population<br />

despite a marked decline in renal function. This is related to the<br />

lower endogenous production of creatinine in the elderly secondary<br />

to their reduced muscle mass. Under-recognition of<br />

renal impairment in the elderly is lessened by the routine<br />

reporting by many laboratories of an estimated GFR (eGFR)<br />

based on age, sex <strong>and</strong> serum creatinine concentration <strong>and</strong><br />

reported in units normalized to 1.73 m 2 body surface area<br />

(mL/min/1.73 m 2 ). When estimating doses of nephrotoxic<br />

drugs, it is important to remember that the drug elimination<br />

depends on the absolute GFR (in mL/min) rather than that normalized<br />

to an ideal body surface area (in mL/min/1.73 m 2 ),<br />

<strong>and</strong> to estimate this if necessary using a nomogram (see<br />

Chapter 7) that incorporates height <strong>and</strong> weight, as well as age,<br />

sex <strong>and</strong> creatinine.<br />

Examples of drugs which may require reduced dosage in<br />

the elderly secondary to reduced renal excretion <strong>and</strong>/or<br />

hepatic clearance are listed in Table 11.1.<br />

The principal age-related changes in pharmacokinetics are<br />

summarized in Figure 11.1.Key points<br />

Key points<br />

Pharmacokinetic changes in the elderly include:<br />

• Absorption of iron, calcium <strong>and</strong> thiamine is reduced.<br />

• There is an increased volume of distribution of fatsoluble<br />

drugs (e.g. diazepam).<br />

• There is a decreased volume of distribution of polar<br />

drugs (e.g. digoxin).<br />

• There is reduced hepatic clearance of long half-life<br />

benzodiazepines.<br />

• Declining renal function is the most important cause of<br />

drug accumulation.<br />

PHARMACODYNAMIC CHANGES<br />

Evidence that the elderly are intrinsically more sensitive to<br />

drugs than the young is scarce. However, the sensitivity of the<br />

elderly to benzodiazepines as measured by psychometric tests<br />

is increased, <strong>and</strong> their effects last longer than in the young. It is<br />

common clinical experience that benzodiazepines given to the<br />

elderly at hypnotic doses used for the young can produce prolonged<br />

daytime confusion even after single doses. The incidence<br />

of confusion associated with cimetidine is increased in<br />

the elderly. Other drugs may expose physiological defects that<br />

are a normal concomitant of ageing. Postural hypotension can<br />

occur in healthy elderly people, <strong>and</strong> the incidence of postural<br />

hypotension from drugs such as phenothiazines, β-adrenoceptor

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!